Analysing of Natural Drugs Plants and Herbal Drugs for Cancer Patients Treatment

The knowledge of Ayurveda has led to the promising use of natural products, particularly plants, in the treatment of various diseases in our country for decades. Herbal drugs are a source of new discoveries in developing countries, and each new drug leads to a new set of healthcare issues and formulations. There are many novel therauptic compounds for preventive and curative drugs in traditional medicines compared to other sources of drug discoveries. Many studies have found antimutagenic and anticancer properties in secondary metabolites like polyphenols, terpenes, and alkaloids. As medicinal plants are antioxidant reservoirs with low toxicity compared to modern drugs, combining Ayurveda with advanced drug discovery may lead to new compounds that address a variety of human sufferings, according to several cancer drug studies and the discovery of new lead molecules towards anticancer activity by using medicinal plants.

A range of clinical studies have indicated that a spectrum of anticancer activities from various herbal drugss can be detected. In this section, we have organized and classified the clinical use of a number of herbal drugss according to their suppressive effect on specific cancer types (Table 1).

Vitamins and selenium have not been proven to play a specific role in the prevention of breast cancer, but in vitro studies have shown some anticancer activities. The vitamin A preparation (Fenretinide) or no treatment was given to 2972 patients with invasive or noninvasive breast carcinoma in one randomised controlled trial. In premenopausal women, the risk of local breast cancer recurrence was significantly reduced 97 months after treatment (HR: 0.65; 95 percent CI: 0.46–0.92). However, there was no discernible difference in terms of metastasis or overall survival [4]. Others have found that taking vitamin E for a long period of time can actually harm breast cancer patients [5, 6]. The current rule appears to cause malabsorption or maldigestion in cancer patients with a concurrent illness, in addition to patients adopting a balanced and healthful diet [4, 7]. Water-soluble isoflavones and lipophilic lignans are the two types of phytoestrogens. In soy beans, isoflavones are abundant, and lignans are found in linseed, wheat, fruit, flaxseed, and vegetables [8, 9]. Linseeds are also rich in lignans. Isoflavone has been linked to a decreased risk of breast cancer in only one of six related clinical trials to date [10]. Women with breast cancer receiving tamoxifen therapy often turn to soy-derived phytoestrogens for relief of postmenopausal symptoms. For example, the isoflavones genistein and daidzein are structurally similar to 17-estradiol and may have weak estrogenic effects [11]. It's not clear

Because prostate cancer has a long latency period, has a strong dietary influence, and has limited treatment options for advanced disease, many patients turn to complementary and alternative medicines (CAM) in the hope that these medicines represent a viable therapeutic option without negative side effects. An evidence-based study is needed to back up the widespread folkloric belief that this is the case. In order to keep the body in a state of homeostasis and avoid various metabolic disorders, people must consume vitamins, including vitamins A–D and retinoids, which are organic compounds that humans cannot synthesise. Inflammation may play a critical role in the development of prostate cancer, according to new research. Vitamin anti-inflammatory activities on prostate carcinogenesis have been studied in a number of clinical trials. Despite the lack of solid evidence, many men with prostate cancer take vitamin and mineral supplements. These supplements are thought to at the very least not harm in the prevention or treatment of inflammation-associated disease. Compared to nonusers, daily intake of >100 IU of vitamin E decreased prostate cancer risk by 56% in smokers who smoked. SELECT, however, a study examining the effects of selenium and vitamin E supplementation on prostate carcinogenesis, found that taking vitamin E in the form of a supplement increased the risk of prostate cancer in otherwise healthy men. Together, these clinical findings suggest that vitamin E treatment for prostate cancer patients may only target inflammation-related symptoms rather than anticancer activity. Future research is required to resolve this apparent discrepancy between the effects seen in healthy individuals versus cancer patients.

Lung cancer is one of the most deadly cancers, and the lung is a common site of metastasis of tumors from other tissues in the body. Standard chemotherapy regimens often have limited survival benefits due to the severe toxicity of the various anticancer agents, such as gemcitabine, paclitaxel, docetaxel, etoposide, and vinorelbine. Recent reports have suggested that herbal drugss and their phytochemicals which seem to have lower or little toxicity may provide an attractive strategy for lung cancer therapy. Traditionally, herbal plants such as Platycodon grandiflorum (Campanulaceae), Morus alba (Moraceae), Prunus armeniaca (Rosaceae), Rhus verniciflua (Anacardiaceae), Perilla frutescens (Labiatae), Stemona japonica (Stemonaceae), Tussilago farfara (Compositae), and Draba nemorosa (Brassicaceae) have been used to treat lung cancer. Clinically, the proportion of patients that use herbal drugss as adjuvants alongside conventional (e.g., chemotherapy) treatment for lung

lung cancer to reduce therapy-associated toxicity and cancer related symptoms and sometimes to directly increase anticancer effects [4]. However, it is important to note that some CAM methods or remedies may have adverse effects or reduce the efficacy of conventional treatment, and the primary justification for use of traditional herbal drugss remains empirical evidence, case studies, and hypothetical physiological effects [4].

Fibrogenesis of the liver is a gradual process of increased extracellular secretion and decreased degradation that can be initiated by activating hepatic stellate cells (HSCs). Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death in the United States. Unfortunately, there are no effective treatments available for HCC patients that are clinically satisfactory. One possible strategy to combat liver fibrosis and HCC is the use of herbal drugs. As far back as ancient China, Japan, and other Asian countries can remember, three medicinal herbs have been used as official drugs. Various chemically induced fibrosis models based on the rat liver system were created in order to test the effectiveness of specific herbal extracts in the treatment of liver fibrosis before clinical trials began. Tested medications include Inchin-ko-to (TJ-135), Yi-Guan Jian (YGJ), and Danggui Buxue Tang (YGJ), as well as Yi-Guan Jian (YGJ) (DBT). Medicinal herbal compounds such as salvianolic acid B (SAB), oxymatrine, and curcumin have been studied for their mechanisms of action in the treatment of hepatic fibrogenesis and carcinogenesis since 2007. It's not known whether or not herbal mixtures such as YGJ, which is traditionally used to treat human liver fibrosis, have any therapeutic or clinical anticancer effects on liver tissue. The discovery of additional active components in these herbal extracts, which are currently unidentified, is critical for their future pharmacological application and improvement. A combination of 10 herbs (named compound 861), including Salvia miltiorrhiza (sage), Astragalus membranaceus, and Spatholobus suberectus known in TCM as the ―king herb‖ components of the formula, that is, the herbs that are pharmacologically active, and seven others (modifiers of toxicity that act synergistically with the king herbs to improve immune function), has been tested in a number of experimental studies for antifibrotic properties. Two uncontrolled open trials of 60 and 22 patients with chronic hepatitis B who were treated with compound 861 reported beneficial effects on liver fibrosis, with the majority of treated patients showing both clinical and histological improvement. Since these clinical studies of compound 861 did not satisfy quality control criteria, clinicians consider that additional well-designed trials are needed for routine and authorized clinical use of compound 861 for the treatment of hepatitis B-induced liver fibrosis.

In both developed and developing countries, cancer is one of the most deadly diseases because of the irregular cell proliferation it causes. When a healthy cell develops into a cancerous one, every change in the body can be observed. Chemotherapy and modern drugs for treating cancer have more side effects because cancer is still the world's second leading cause of death despite the availability of many treatments. Millions of people are diagnosed with cancer each year, and many of them succumb to it and die. Every year, cancer claims the lives of approximately 3500 million people around the world, or roughly 2-3 percent of all annual deaths. Chemopreventive agents have had some success in the treatment of cancer, but their use is discouraged due to the toxicity they cause. 5,6. Chronic inflammation is caused by factors such as smoking, dietary imbalances, hormones, and infections that last a long time. Because chemotherapy and radiation therapy have such severe side effects, finding more effective and less harmful treatments should happen right away. Anti-cancer measures include healthy eating habits, not smoking, effective treatment of inflammatory diseases, and the use of nutritional supplements that boost the immune system. Unfortunately, chemotherapy, which is currently the only major treatment option for advanced-stage cancers, has a high level of toxicity when administered to healthy tissues. Podophyllotoxin was discovered in the late 1960s, and the search for natural cancer drugs continued with the discovery of vincristine, vinblastine, campthothecin, and taxol. More than a thousand plant species have been found in nature to be anti-cancer. Oncologists have found great success with Taxol in treating cancers like ovarian, breast, and other small cell types. A synthetic modification of this drug's structure led to Etoposide, a drug that has been shown to be effective in treating cancers like lung and testicular small cell types. If medicinally important herbs and their mechanisms of action could be discovered, a new and more effective treatment for cancer prevention would be available. Potent compounds isolated from medicinal plants have been the source of a slew of new drugs for decades. The process of drug discovery and development includes three main following research approaches (1) Bioactivity- based on mechanism of specific action-directed isolation and characterization of active compounds, (2) Rational drug design - involves modification and synthesis of analog, and (3) Mechanism of action studies. traditional drugs and Ayurvedic knowledge to find new drug leads with high activity but low toxicity for cancer therapy. The Indian subcontinent continues to use traditional medicines to treat a wide range of ailments, thanks in part to the region's rich botanical diversity. Medical plants have been used as a remedy for a variety of human ailments according to ethnohistorical accounts. This is because medicinal plants contain large amounts of powerful chemical compounds that act as curative drugs with fewer side effects. Natural medicines have become increasingly important in the healthcare system, impacting both global health and international trade. Because most people in developing countries have low incomes and Western drugs are expensive, herbal drugs have been used by a large proportion of the population for a long time. These countries are more open to the use of herbal drugs because of their religious and cultural traditions. Cancer is likely to be the most important genetic disease for which medicinal plants can be used as treatment. See fig. 1.

Microtubulin assembly into coiled spiral aggregrates induced by selfassociation of tubulin is under the influence and mode of action of Vincristine. Etoposide is a topoisomerase II inhibitor causes DNA breaks, whereas topoisomerase I is inhibited by the action of Docetaxel. Drugs made of synthetic chemistry and use of technological combinatorial chemistry in the synthesis of new leads , still today drugs derived from natural product make an enormous contribution to drug discovery. Nature is an attractive source of new therapeutic candidate compounds as a tremendous chemical diversity is found in millions of species of plants, several plant derived compounds are currently successfully employed in cancer treatment.

Over 3 million people die each year from cancer, according to the American Cancer Society. Research cases. Some plants may contain properties that naturally have the ability to prevent the spread of cancer or the risk of developing various types of cancer by using the antioxidant, anticancer activities that are known to inhibit or kill carcinogenic cells in medicinal plants. Some examples of plants that may be used for cancer treatment are discussed with their respective advancements are listed in below Table No. 2.

Numerous Chinese herbal drugss are being used in combination with chemotherapy or radiotherapy to improve the efficacy of cancer therapy and reduce side effects and complications (Figure 2), although this practice is highly frowned upon by many western physicians. Understanding of the use of specific herbal drugss as adjuvants to conventional therapy, therefore, needs to be increased in consultation and coordination with physicians and other health care providers. This section outlines evidence for use of herbal drugss as adjuvants to conventional drug-based, chemo- or radiotherapy regimes in cancer treatment.

Most clinical trials now use randomised controlled trials (RCTs) (also known as randomised comparative trials) as the gold standard to determine the effectiveness of healthcare interventions. As a result, the best estimates of treatment effect are obtained from well-planned and well-executed RCTs, and this information is used to guide clinical decision-making. For example, herbal drug trials may be superior to homoeopathy and acupuncture trials in terms of reporting quality, as noted by Linde et al. Furthermore, the quality of reporting varied greatly across different botanical drugs and continued to improve steadily over the course of several decades, from the 1980s through the 2000s. The controversy over herbal drug trials led an international group of pharmacologists, methodologists and pharmacognosists to convene in June 2004 for the purpose of developing recommendations for the reporting of herbal drug trials in Toronto, Canada. As a result of this meeting, a consensus document was developed. In order to assist researchers in better assessing the internal/external validity and reproducibility of herbal drug trials, an expansion of the CONSORT statement was proposed, allowing for a more accurate assessment of the safety and effectiveness of herbal drugs. One item (item 4 (interventions)) received detailed recommendations, while eight other items (item 1 (titre and abstract), item 2 (background), item 3 (participants), item 6 (outcomes), item 15 (baseline data), item 20 (interpretation), item 21 (generalizability), and article 22 [overall evidence] received minor recommendations. Item 4's specific recommendation addressed the herbal drugs intervention's concerns, which still require in-depth elaboration. These suggestions were made to help researchers better report RCT findings. Despite the fact that TCM and other herbal medicines are widely used around the world, their efficacies have only been studied on a sporadic basis, with very few studies that were properly randomised and controlled. Studies by Mok and colleagues and Chan and colleagues, for example, have used high standards of clinical trial methodology. Mok and his colleagues looked into the possibility that Chinese herbal medicines could help reduce the toxicity caused by chemotherapy. In patients with early-stage breast or colon cancer, traditional Chinese herbal medicines appeared to have a significant impact on nausea control, but these herbal medicines did not reduce the hematologic toxicity of chemotherapy. To find out whether or not the test TCMs improved QOL and decreased the side effects of systemic chemotherapy, Chan et al. performed a random, placebo-controlled trial on patients being treated with an established treatment for ovarian cancer. Additionally to standard chemotherapy, ovarian cancer patients were randomised to receive either the experimental TCM formulation or a placebo. Using the Global Health Status (GHS) score and the European Organization for questionnaire, the primary outcome was recorded. Secondary outcomes included other quality-of-life (QOL) items, chemotoxicity levels determined using WHO criteria, and immune system alterations. According to the findings, TCM had effects on immune function maintenance (e.g., lymphocyte count and cytokine activities) rather than quality of life improvement. Even though these randomised trials fell short of their enrollment goals, we may be forced to draw the conclusion that further systematic research with RCTs is needed in order to fully evaluate and demonstrate specific bioactivities and the benefits of different traditional Chinese medicine (TCM) formulations and plant extracts for cancer patients.

Herbal properties found in medicinal plants aid in the discovery of new drugs to treat a wide range of disorders and diseases, including cancer, without harming the people being treated. Ayurvedic cancer treatment using natural products and traditional medicines is becoming increasingly important in the field of cancer research. Traditional medicines, medicinal plants in cancer treatment, and anti-cancer properties of natural products were briefly discussed in this review. The anticancer properties of medicinal plants come from their combination of Immunomodulatory and antioxidant properties. Only a small number of the approximately 1000 species of plants have been studied for biological activity, so additional research into the anticancer activity of the plants that show promising activity must be carried out. A powerful anticancer drug is vinca rosea alkaloids Vinblastine and Vincristine, which come from the plant Vinca rosea. Taxol, a compound derived from the leaves of the Taxus brevifolia plant, has found wide application in the treatment of cancer. According to the findings of this review, cancer is the leading killer in developing nations like India. For rural and poor people, herbal drug treatment may be a highly recommended option for treating cancers of various types effectively.

1. Gupta AK and Tandon N (2004). Reviews on Indian Medicinal Plants. New Delhi: Indian Council of Medical Research. 2. Izevbigie EB (2003). Discovery of water-soluble anticancer agents (edotides) from a vegetable found in Benin City, Nigeria. Exp Biol Med (Maywood); 228: pp. 293-298. 3. Om Prakash, Amit Kumar, Pawan Kumar, and Ajeet,(2013). ―Anticancer Potential of Plants and Natural Products: A Review.‖ American Journal of Pharmacological 4. Krishnamurthi K. (2000). Screening of natural products for anticancer and antidiabetic properties. Health Administrator. XX; (1&2): pp. 69. 5. K. Srinivas; A.J Afolayan (2007). Current Science; 92, pp. 906-8. 6. K.Kathiresan; N.S Boopathy; S. Kavitha (2006). Natural Product Radience; 5, pp. 115-19. 7. B.N Ames; L.S Gold (1995). The cause and prevention of cancer. Proceedings of the National Academy of Sciences USA; 92, pp. 5258-65 8. S. Madhuri; G. Pandey (2009). Current Science; 96, 6, pp. 779-83. 9. A.P Somkumar (2003). Study on anticancer effects of Ocimum sanctum and Withania somnifera on experimentally induced cancer in mice. PhD thesis. J N K V V Jabalpur. 10. S. Madhuri; G. Pandey (2006). Indian drugs; 43, pp. 869-74 11. M. Umadevi, K.P.Sampath Kumar, Debjit Bhowmik, S. Duraivel (2013). Traditionally Used Anticancer Herbs In India. Journal of Medicinal Plants Studies; Volume: 1, Issue: 3, pp. 56-74. 12. Gordon M. C., David J. (2005). Plants as a source of anti-cancer agents. Journal of Ethno pharmacology; 100. Pp. 72. 13. Lee KH. Human medicinal agents from plants. In: Kinghorn AD, Balandrin M, editors. (1993). ACS Symposium Series No. 534.Washington, DC: American Chemical Society; Chap.12 14. M. C. Shun, W. Yu, A. Gapor et. al. (2014). ―Pro-apoptotic mechanisms of action of a novel vitamin E analog (𝛼-TEA) and a naturally occurring form of vitamin E (𝛿-Tocotrienol) in MDA-MB-435 human breast cancer cells,‖ Nutrition and Cancer, vol. 48, no. 1, pp. 95–105. 15. B. Gerber, C. Scholz, T. Reimer, V. Briese, and W. Janni (2016). ―Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review,‖ Breast Cancer Research and Treatment, vol. 95, no. 3, pp. 199–209.

Research Scholar, North East Frontier Technical University, Aalo, Arunachal Pradesh